» Authors » Andrew Knox

Andrew Knox

Explore the profile of Andrew Knox including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 239
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Bryant A, Knox A
Aust Fam Physician . 2015 Mar; 44(3):102-5. PMID: 25770573
Background: An ingrown toenail or onychocryptosis may occur at any age and is the mostly commonly encountered toenail problem likely to be seen in general practice. Objective: This article will...
22.
Doherty W, James J, Evans P, Martin L, Adler N, Nolan D, et al.
Org Biomol Chem . 2014 Aug; 12(38):7561-71. PMID: 25137249
An improved, Weinreb amide-based, synthesis of anti-trypanosomal lysine-containing vinyl sulfones is described incorporating, as a feature, diversity at the ε-lysine amino group. Members of this family demonstrated moderate to good...
23.
Knox A, Mykhaylova N, Evans G, Lee C, Karney B, Brook J
Sci Total Environ . 2012 Oct; 448:189-96. PMID: 23040176
This paper explores technologies currently expanding the physical scope of air pollution monitoring and their potential contributions to the assessment of sustainable development. This potential lies largely in the ability...
24.
Knox A, Schneider A, Abucayan F, Hervey C, Tran C, Hessl D, et al.
J Neurodev Disord . 2012 Sep; 4(1):2. PMID: 22958782
Background: Attention and inhibition are core executive-function deficits in FRagile X syndrome (FXS). This pilot study evaluated the feasibility, reproducibility, and clinical relevance of the KiTAP, a computer-based pictorial measure...
25.
Berry-Kravis E, Knox A, Hervey C
J Neurodev Disord . 2011 Apr; 3(3):193-210. PMID: 21484200
Fragile X syndrome (FXS) is the most common identifiable genetic cause of intellectual disability and autistic spectrum disorders (ASD), with up to 50% of males and some females with FXS...
26.
Warnock L, Knox A, Mee T, Raines S, Milner J
Cancer Biol Ther . 2008 Sep; 7(9):1481-9. PMID: 18769132
The tumor suppressor protein p53 is considered the "Guardian of the Genome", crucial for cell cycle control and mutated in over 50% of human cancers. Following cellular stress, post-translational modifications...